Skip to main content

In Search of A Rhythmic Heartbeat with AFib?

Explore Atrial Fibrillation Clinical Trials for Potential Novel Treatment Options!

Atrial fibrillation (AFib) is a type of irregular heartbeat that affects the atria, the upper chambers of the heart. According to statistics, AFib causes about 1 in 7 strokes.

The majority of strokes associated with AFib are ischemic strokes, which occurs when a blood clot forms within an artery that supplies blood to the brain. To reduce the risk of stroke in AFib, anticoagulation therapy is often prescribed.

Revival Research Institute is conducting AFib trial exploring potential new treatment options that may reduce the risk of blood clot formation.

You may qualify for Atrial Fibrillation Clinical Trials if you:

  • Are at least 18 years or older
  • Have been diagnosed with Atrial Fibrillation

*Participating in the AFib trial is at no cost to you or your private medical insurance. You will be reimbursed for your time and travel. In addition, all participants receive study-related care, free of cost from an experienced research team.
**If you are interested in participating in the Atrial Fibrillation Clinical Trials or would like more information, please fill out the form so we can determine if you qualify for the study and contact you. Note that this is an entirely voluntary decision.

Please provide YOUR contact information only.
Atrial Fibrillation Clinical Trials in Michigan

About the Atrial Fibrillation Clinical Trials (Michigan)

AFib (Atrial Fibrillation) is a common heart rhythm condition that affects millions of people throughout the world. It happens when the electrical signals in the heart become disorganized, causing the top chambers (atria) to quiver or fibrillate instead of contracting correctly. This irregular heartbeat can result in a variety of consequences, such as blood clots, stroke, heart failure, and other cardiovascular issues.

We are conducting Atrial Fibrillation Clinical Trials to assess and compare the safety and efficacy of a pre-existing drug with the investigational drug. It will also evaluate if the investigational drug keeps blood clots from forming while reducing the risk of bleeding in people with AFib. Throughout the duration of the AFib trial, participants will receive study-related care from qualified healthcare professionals.

**The study drug, related procedures, and visits will be provided at no charge for the duration of the study.

Get Started: What to Expect?

If you decide to participate in the AFib trial by filling out the form above, someone from the study team will contact you to determine your eligibility. The study doctors will go over the study details with you and see if you meet the eligibility criteria for the Atrial Fibrillation Clinical Trials.

If you meet the criteria, you will be invited to the study location for screening. The study site will be within a 50-mile radius of your current location. The study doctors will advise you on the duration of the atrial fibrillation clinical trials and the implications of your involvement in this research study. We invite you to ask as many questions as you like. After everything has been thoroughly explained to the participants, they will be requested to sign an Informed Consent Form.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians and health care experts.

Study Duration

4 years

Number of study visits

2 to 16



About Atrial Fibrillation

With increasing age and comorbidities, patients with AFib have a 5-fold increased risk of stroke than those without AFib. The treatment of stroke depends on the severity of the condition. Here is a list of symptoms, causes and risk factors of AFib.


Symptoms can range from mild to severe and at times people who have the condition might not experience any symptoms at all. However, some of the common symptoms include:

  • Irregular heartbeat
  • Heart palpitations
  • Light-headedness
  • Extreme fatigue
  • Shortness of breath
  • Chest pain


Some of the common causes of AFib include:

  • Family history
  • Abnormal or damaged heart structure
  • High blood pressure
  • Stress
  • Sleep apnea
  • Improper functioning of the sinus node (heart’s natural pacemaker)
  • Obesity

Risk Factors

AFib risk increases with age. Risk factors for AFib include:

  • High blood pressure
  • Obesity
  • Diabetes
  • Heart failure
  • Hyperthyroidism
  • Chronic kidney disease
  • Ischemic heart disease
  • Smoking
  • Enlargement of left side chambers of the heart

Frequently Asked Questions

What is Atrial Fibrillation (AFib) and why is it a problem?

Atrial Fibrillation is an irregular or abnormal heartbeat that begins as short periods of irregular beating, with increased duration, over time. It may be a problem as when the heart is in AFib, it is unable to pump oxygen-rich blood throughout the body leading to complications such as formation of blood clots which eventually leads to stroke, or heart failure.

What is the greatest risk of AFib?

The greatest risk of AFib is stroke as it causes the blood to pool and move slower than usual. This can result in a clot, that eventually may lead to stroke.

Where can I learn more about Atrial Fibrillation Clinical Trials location?

The AFib trials are being carried out in Michigan. For more information on our sites and their location, please visit the Locations page. Once our research team reaches out to you, we will guide you and provide you with complete details of the location of the site.

Is AFib a fatal condition?

AFib is not a fatal condition itself, however it may lead to complications such as stroke, and heart failure, both of which can be life-threatening if not treated timely.

Close Menu